REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

Similar documents
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Select Inhaled Respiratory Agents

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

A Visual Approach to Simplifying Respiratory Drug Regimens

FASENRA (benralizumab)

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

The Medical Letter. on Drugs and Therapeutics

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

STRIVERDI RESPIMAT (olodaterol hcl) aerosol

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol

COPD Update. Plus New and Improved Products for Inhaled Therapy. Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

Asthma COPD Update 2018

COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Asthma/COPD P&T DATE 12/14/2017 CLASS:

Drug Effectiveness Review Project Summary Report

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

MDI Bonanza. Dwayne Griffin, DO

Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients

Diagnosis and Management of Asthma

University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016)

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

Asthma/COPD Update with Inhaler Workshop

Asthma. Definition. Symptoms

Three s Company - The role of triple therapy in chronic obstructive pulmonary

End Stage COPD Guidance Document

reslizumab (Cinqair )

Asthma & COPD Medication Review. Hutchison Disclosures 2/16/2017. Objectives

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

Balanced information for better care. Helping patients with COPD breathe easier

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Pequot Health Care Smart Quantity Program*

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Foundations of Pharmacology

Asthma/COPD Update with Inhaler Workshop

Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18

Objectives. Speaker has no relationship to disclose. Sneezes, Wheezes, and Respiratory Diseases: An update on Asthma, Allergic Rhinitis,

Michelle Zeidler, MD, MS

COPD: Treatment Update Property of Presenter. Not for Reproduction. Barry Make, MD Professor of Medicine National Jewish Health

Pain Oral-Intranasal Fentanyl (Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys)

Methacholine Challenge Test

Drug Class Monograph

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

COPD. Understanding. An educational health series from National Jewish Health IN THIS ISSUE. What is COPD? 2. How is COPD Managed?

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida

A Patient s Guide to Aerosol Medication Delivery

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

Chronic Obstructive Pulmonary Disease

COPD Robert Schilz DO, PhD Pulmonary, Critical Care and Sleep Medicine University Hospitals Case Medical Center

9/14/12. Nicole Paterson, PharmD BCPS Medication Therapy Management Provider Fairview Pharmacy Services, LLC

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

Secretary for Health and Family Services Selections for Preferred Products

MEDICAID QUANTITY LIMIT DRUG LIST

MANAGING ASTHMA. Nancy Davis, RRT, AE-C

See Important Reminder at the end of this policy for important regulatory and legal information.

Nancy Davis, RRT, AE-C

Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management

See Important Reminder at the end of this policy for important regulatory and legal information.

Objec9ves. Drug Classes with Indications to Treat AR. Allergic Rhinitis. Allergic Rhinitis. Action Statements

Provider Respiratory Inservice

Pulmonary Medication Toolkit: Is yours up to date?

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption

Key features and changes to these four components of asthma care include:

What You Need to Know about Metered-Dose Inhalers and the HFA Propellant

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

Individualizing and Optimizing Asthma Care. CFW 2018 Friday, April 13, 9:45 11:15 am Renaissance Austin Hotel in Austin, Texas

Allergy and Immunology Patient Questionnaire

4/3/2018 BRANDY BURGESS, APRN-CNS, MSN-RN APRIL 12-14, 2018

benralizumab (Fasenra )

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma

Medications Affecting The Respiratory System

Report generated from BNF provided by FormularyComplete ( Accessed Formulary Status. TA Number. Section.

Take My Breath Away COPD Update. Take My Breath Away COPD Update 4/16/16. Juliann Horne, PharmD, PhC, BCACP

Diabetes Fortamet (metformin ER), Glumetza (metformin ER) generic of Glucophage XR (metformin ER) preferred

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?

Correct Use of Inhaler Devices

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Improving Outcomes in COPD

See Important Reminder at the end of this policy for important regulatory and legal information.

Nucala (mepolizumab injection for subcutaneous use)

COPD. Definitionn. make. when (bronchioles) in. the lungs. Wheezing Chest tightness. your lungs. greenish. Lack of energy

Take My Breath Away: COPD Update. Jason Henderson D.O. Warren Clinic Pulmonary & Critical Care

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy

The Latest Medications A Pharmacological Update for RTs

Incorporating Newer Therapies and Strategies to Improve COPD Outcomes: A Practical Guide for Pharmacists. Learning Objectives.

Test Your Inhaler Knowledge

Blue Cross KeyRx TK Preventive RX Pack Drug List Large Group Effective January 1, 2019

Risk Factors for the Development of COPD

Advanced Pharmacology Respiratory Pharmacology

Inhaled Corticosteroid Dose Comparison in Asthma

Reference Guide for Caring for Pediatric Patients with Asthma

Clinical Policy: Mepolizumab (Nucala) Reference Number: ERX.SPA.214 Effective Date:

Transcription:

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE ID NUMBER: 0a) Date of Collection / / 0b) Staff Code Instructions: This form should be completed during the participant s clinic visit. 1) Are you regularly using (at least once on most days) any inhaled medications? No 0 Go to 2 If Yes, please indicate which inhaled medication(s) you use regularly (check all that apply): 1a) Proventil, Ventolin, ProAir (albuterol) inhaler 1b) Xopenex or Generic (levalbuterol) inhaler 1c) Atrovent (ipratropium) inhaler 1d) Combivent (ipratropium/albuterol) inhaler 1e) Flovent (fluticasone) 1f) Arnuity Ellipta (fluticasone) 1g) Qvar (beclomethasone) 1h) Pulmicort (budesonide) 1i) Asmanex (mometasone) 1j) Alvesco (ciclesonide) 1k) Serevent (salmeterol) 1l) Striverdi (olodaterol) 1m) Arcapta (indacaterol) Neoinhaler 1n) Spiriva (tiotropium) 1o) Incruse (umeclidinium) 1p) Tudorza (aclidinium) 1q) Seebri Neohaler (glycopyrrolate) 1r) Anoro Ellipta (umeclidinium-vilanterol) 1s) Utibron (glycopyrrolate-indacaterol) 1t) Bevespi Aerosphere (glycopyrrolate formoterol) 1u) Stiolto (tiotroprium-olodaterol) 1v) Advair (fluticasone-salmeterol) 1w) Breo Elipta (fluticasone-vilanterol) 1x) Dulera (mometasone-formoterol) 1y) Symbicort (budesonide-formoterol) Revised Respiratory Medication Use Questionnaire, RRM Page 1 of 6

1z) Air-duo & Generic (fluticasone- salmeterol) 1z1) Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) 1z2) Other 1z2a) Please specify other 2) Are you regularly using any nebulized medications? No 0 Go to 3 2a) How often (daily versus as needed when having difficulties)? Daily 1 As needed when having difficulties 2 2b) Which medications? (check all that apply) 2b1) AccuNeb (albuterol sulfate) nebulizer 2b2) Xopenex (levalbuterol) nebulizer 2b3) Atrovent (ipratropium) nebulizer 2b4) DuoNeb (ipratropium bromide/albuterol) nebulizer 2b5) Perforomist (formoterol) nebulizer 2b6) Brovana (arformoterol) nebulizer 2b7) Pulmicort (budesonide) nebulizer 2b8) 3% Hypertonic saline 2b9) 7% Hypertonic saline 2b10) Other 2b10a) Please specify other 3) Are you regularly using any of the following oral medications? No 0 Go to 4 If Yes, please indicate the oral medications regularly used. (check all that apply) 3a) Theo-24, Theochron, or generic (theophylline) 3b) Daliresp (roflumilast) 3c) Zithromax, daily or several days each week (azithromycin) 3d) Accolate (zafirlukast), Singulair (montelukast), Zyflo (zileuton) Revised Respiratory Medication Use Questionnaire, RRM Page 2 of 6

4) Are you currently using oral corticosteroids (prednisone, Medrol, dexamethasone, hydrocortisone)? No 0 Go to 5 4a) How long have you been on this medication? years days 5) Are you regularly using any of the following nasal sprays? No 0 Go to 6 If Yes, please indicate the nasal sprays regularly used. (check all that apply) 5a) Omnaris, Flonase, Veramyst, Beconase, Rhinocort, Flunisolide, Nasacort (nasal steroids) 5b) Atrovent (ipratropium) 5c) Afrin (oxymetazoline) 6) Are you currently using supplemental oxygen (prescribed by your doctor) at home? No 0 Go to 7 6a) Approximately how many hours in a 24-hour period do you use oxygen? hours 6b) If you are using nighttime supplemental oxygen, do you use oxygen only at night? No 0 7) Are you currently using any statin medications (listed below)? No 0 Go to 8 7a) If Yes, please indicate which statin medication you use regularly? Crestor (rosuvastatin) 1 Lescol (fluvastatin) 2 Lipitor (atorvastatin) 3 Mevacor (lovastatin) 4 Pravachol (pravastatin) 5 Vytorin (ezetimibe, simvastatin) 6 Zocor (simvastatin) 7 Other 8 7a1) Please specify other Revised Respiratory Medication Use Questionnaire, RRM Page 3 of 6

8) Are you currently using any beta-blocker medications (listed below)? No 0 Go to 9 8a) If Yes, please indicate which beta-blocker medication you use regularly? Tenormin, Tenoretic (atenolol) 1 Lopressor, Toprol (Metoprolol) 2 Coreg (carvedilol) 3 Trandate, Normodyne (labetalol) 4 Inderal, Inderide (propranalol) 5 Betapace, Sorine (Sotalol) 6 Blocardren, Timolide (timolol) 7 Zebeta, Ziac (isoprolol) 8 Visken (pindolol) 9 Other 10 8a1) Please specify other 9) Are you currently using any oral anti-oxidant supplements (listed below)? No 0 Go to 10 If Yes, please indicate which supplement(s) you use regularly? (check all that apply) 9a) Vitamin C (ascorbic acid) 9b) Vitamin E (alpha-tocopherol) 9c) Beta carotene 9d) Zinc 9e) Copper 9f) Fish oil 9g) Omega 3 9h) Other 9h1) Please specify other 10) Are you currently using aspirin or any of the following anticoagulants? No 0 Go to 11 If Yes, please indicate aspirin or anticoagulants you use regularly? (check all that apply) 10a) Aspirin 10b) Plavix (clopedigel) 10c) Coumadin (warfarin) 10d) Xarelto, Eliquis, Pradaxa, Savaysa (rivaroxaban, apixaban, dabigatran, edoxaban) Revised Respiratory Medication Use Questionnaire, RRM Page 4 of 6

11) Are you currently using or have you used nicotine replacement therapy (gum, patch, lozenge, or spray)? No, have never used 0 Yes, currently using 1 Yes, have used in the past, but not currently using 2 12) Are you currently using or have you used a prescription medication for tobacco cessation? No, have never used 0 Yes, have used in the past, but not currently using 1 Yes, currently using Chantix (varenicline) 2 Yes, currently using Zyban (bupropion) 3 13) Are you currently using or have you used any other medications (prescribed or over the counter) regularly in the past 3 months that are not listed above? No 0 Go to 14 If Yes, please list any other medications (prescribed or over the counter) not listed above: 13a) 13b) 13c) 13d) 13e) 13f) 13g) 13h) 13i) 14) Are you currently using or have you used any other supplements regularly in the past 3 months that are not listed above? No 0 End Form If yes, please list any other supplements not listed above: 14a) 14b) 14c) 14d) Revised Respiratory Medication Use Questionnaire, RRM Page 5 of 6

14e) 14f) 14g) 14h) 14i) END OF FORM Revised Respiratory Medication Use Questionnaire, RRM Page 6 of 6